Contact
Please use this form to send email to PR contact of this press release:
ASLAN Pharmaceuticals Announces Study Results from Phase 2 Study of Varlitinib in First-line Gastric Cancer
TO:
Please use this form to send email to PR contact of this press release:
ASLAN Pharmaceuticals Announces Study Results from Phase 2 Study of Varlitinib in First-line Gastric Cancer
TO: